Diabetes News and Research

Latest Diabetes News and Research

Diabetes Research Institute kicks off 'Be Part of the CURE' online campaign

Beginning today, thousands of people who want to help put an end to diabetes can be part of the cure by participating in the Diabetes Research Institute Foundation's online campaign at BePartoftheCure.org. Kicking off National Diabetes Awareness Month, the Be Part of the CURE campaign is a fun and meaningful way for people living with diabetes, their family and friends, and anyone concerned about curing this devastating disease to literally participate in the "CURE."

1 Nov 2010

Mechanism of rogue cell killer discovered

A team of Melbourne and London researchers have shown how a protein called perforin punches holes in, and kills, rogue cells in our bodies. Their discovery of the mechanism of this assassin is published today in the science journal Nature.

1 Nov 2010

Study determines long-term clinical outcome of patients posttransplant after anitviral therapy

Researchers from the University of Bari, Italy, concluded that treating patients after transplantation with antiviral therapy creates a sustained viral response (SVR) and protects them from liver-related deaths. The purpose of this study was to determine the long-term clinical outcomes of patients posttransplant who underwent antiviral therapy for recurrent hepatitis C virus (HCV) infection of the liver graft.

1 Nov 2010

Scientists use electron microscopes to study mechanism of perforin protein to punch holes in rogue cells

Scientists from the UK and Australia have seen the human immune system's assassin a protein called perforin in action for the first time. The UK team, funded by the Biotechnology and Biological Sciences Research Council (BBSRC) and the Wellcome Trust, is based at Birkbeck College where they used powerful electron microscopes to study the mechanism that perforin uses to punch holes in rogue cells.

1 Nov 2010

FDA new approvals, antibiotic and neurological drugs

Two new drugs have gained approval from the US Food and Drug Administration (FDA) – one is an antibiotic from Forest Labs and the other a first-time treatment for a neurological disorder developed by Avanir Pharmaceuticals. Another waiting for approval is Biodel's fast-acting insulin Linjeta. On the other hand seven new drugs got rejected including a diabetes drug from Amylin Pharmaceuticals and weight-loss drugs from Arena Pharmaceuticals and Vivus, respectively.

31 Oct 2010

Proteins to punch holes in cancer cells to kill them: Study

In a medical breakthrough scientists have found a protein called perforin that kills rogue cells in the human body especially the ones causing cancer. The team comprising of experts from Melbourne and London found that perforin punches holes and kills these cells. The research appeared in the acclaimed journal Nature.

31 Oct 2010

Summit discusses value, cost-effectiveness of America's investment in wellness and prevention

America's historic investment in wellness and prevention mandated under the Affordable Care Act may not always save money – but it will be worth it.

30 Oct 2010

Researchers discover agouti family gene regulates pigmentation, body weight

Researchers led by Vanderbilt's Roger Cone, Ph.D., have discovered a new member of a gene family that has powerful influences on pigmentation and the regulation of body weight.

30 Oct 2010

Experts at XXXIII World Congress present new clinical challenges about thrombotic disorders

Pharmaceutical Strategic Initiatives announced today that some of the leading experts in the field of thrombosis and anticoagulation provided their perspective and assessment of new clinical challenges at a recent symposium held at the XXXIII World Congress of the International Society of Hematology held in Jerusalem, Israel on October 12, 2010.

30 Oct 2010

New sculpture to commemorate Sir Frederick Banting

One of the greatest gifts Canada has given the world will be celebrated this Sunday at Banting House National Historic Site of Canada located in London, Ont. with the unveiling of a three-metre high sculpture to commemorate the birth of Sir Frederick Banting's brilliant idea that led to the discovery of insulin. Banting House National Historic Site of Canada is a public site dedicated to the historic significance of Sir Frederick Banting.

30 Oct 2010

Joslin announces fundraisers to benefit diabetes research

The importance of the research and clinical care work at Joslin Diabetes Center in Boston has been affirmed by a report from the Centers for Disease Control and Prevention predicting that one-third of all U.S. adults will have diabetes by 2050 if current trends continue.

30 Oct 2010

Study finds SBRT therapy delays pancreatic cancer progression

For pancreatic cancer patients unable to undergo surgery the only known cure for this form of cancer a highly targeted cancer radiation therapy may help slow cancer progression and lessen disease symptoms, according to researchers at Henry Ford Hospital in Detroit.

30 Oct 2010

BioMedix receives ONC-ATCB 2011/2012 certification for TRAKnet Practice Management Software

BioMedix announced today that TRAKnet Practice Management Software 2.0 is 2011/2012 compliant and was certified as a Complete EHR on October 28th, 2010 by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable Eligible Provider certification criteria adopted by the Secretary of Health and Human Services.

30 Oct 2010

Roche announces U.S. introduction of cobas e 602 analyzer

Roche announced today the U.S. introduction of the cobas e 602 analyzer, the latest addition to the cobas 8000 modular analyzer series for diagnostic labs with high-volume workloads. Labs will now be able to combine this new immunoassay module with two existing clinical chemistry modules to create an integrated platform with 24 unique system configurations to match their specific testing needs.

From Roche Sequencing and Life Science 30 Oct 2010

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

An endocrinologist in the University at Buffalo's School of Medicine and Biomedical Sciences has received a three-year $400,000 Junior Faculty Award from the American Diabetes Society to study the effects of low testosterone levels in young men with type 2 diabetes.

30 Oct 2010

Study suggests curcumin may be an effective therapy for liver fibrosis

Curcumin, a chemical that gives curry its zing, holds promise in preventing or treating liver damage from an advanced form of a condition known as fatty liver disease, new Saint Louis University research suggests.

30 Oct 2010

MannKind third quarter operating expenses decreases from $42.8 million to $42.5 million

MannKind Corporation today reported financial results for the third quarter ended September 30, 2010.

29 Oct 2010

Merck reports $342 million net income for 2010 third quarter

Merck & Co., Inc. today announced financial results for the third quarter of 2010. The company reported non-GAAP (generally accepted accounting principles) earnings per share (EPS) for the third quarter of $0.85, which excludes purchase accounting adjustments, restructuring costs, merger-related expenses and a $950 million legal reserve.

29 Oct 2010

Dental health affects control of diabetes

Diabetes is a disease that affects every part of the body, and for people with unstable blood glucose levels there is a higher risk than normal for developing serious complications from poor oral hygiene. In a study by dLife, the world's largest diabetes community, and SoundView Research, Inc., 66 percent of active diabetes managers had not changed their oral care habits since being diagnosed and over half have not been advised by their dentist to take extra care to brush, floss, or rinse daily.

29 Oct 2010

EUCOMMTOOLS partners to receive 12 million euros research funding from European Commission

The findings will contribute to a better understanding of the pathogenesis of widespread diseases such as Alzheimer's, depression, diabetes, chronic lung diseases or cancer. Over the next five years, the eight EUCOMMTOOLS partners, coordinated by Professor Wolfgang Wurst of Helmholtz Zentrum M-nchen, will receive research funding amounting to approximately 12 million euros from the European Commission.

29 Oct 2010

Diabetes News and Research

Latest Diabetes News and Research

Diabetes Research Institute kicks off 'Be Part of the CURE' online campaign

Mechanism of rogue cell killer discovered

Study determines long-term clinical outcome of patients posttransplant after anitviral therapy

Scientists use electron microscopes to study mechanism of perforin protein to punch holes in rogue cells

FDA new approvals, antibiotic and neurological drugs

Proteins to punch holes in cancer cells to kill them: Study

Summit discusses value, cost-effectiveness of America's investment in wellness and prevention

Researchers discover agouti family gene regulates pigmentation, body weight

Experts at XXXIII World Congress present new clinical challenges about thrombotic disorders

New sculpture to commemorate Sir Frederick Banting

Joslin announces fundraisers to benefit diabetes research

Study finds SBRT therapy delays pancreatic cancer progression

BioMedix receives ONC-ATCB 2011/2012 certification for TRAKnet Practice Management Software

Roche announces U.S. introduction of cobas e 602 analyzer

UB endocrinologist receives Junior Faculty Award to study effects of low testosterone in young men with type 2 diabetes

Study suggests curcumin may be an effective therapy for liver fibrosis

MannKind third quarter operating expenses decreases from $42.8 million to $42.5 million

Merck reports $342 million net income for 2010 third quarter

Dental health affects control of diabetes

EUCOMMTOOLS partners to receive 12 million euros research funding from European Commission

Industry Focus eBook - Medical device (1st edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Diabetes News and Research

Latest Diabetes News and Research

Industry Focus eBook - Medical device (1st edition) eBook

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Bioprocess Efficiency with Cell Density Monitoring

Newsletters you may be interested in